• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Sodium Hypophosphite
Sodium Persulfate
Sodium Sulfate Anhydrous
Soda Ash (Light)
Soda Ash (Dense)
Sodium Nitrite

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

April 27, 2023

Tag:

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

Previous:350 million project construction started, and the development potential of TUL was accelerated

Next:First in China! The weight management medicine of Smeglutide Injection of TUL was approved for clini

You may like
More>>

Sulfuryl chloride(7791-25-5)

Sulfuryl chloride(7791-25-5)
Tinidazole and Sodium Chloride Injection

Tinidazole and Sodium Chloride Injection
Epimedium Extract 50% Icariin

Epimedium Extract 50% Icariin
Vitamin U

Vitamin U
glucosamine+calcium tablets

glucosamine+calcium tablets
Iguratimod Impurity K

Iguratimod Impurity K
N-Hydroxysuccinimide

N-Hydroxysuccinimide
3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one

3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one
Medical blister packaging supply Oral liquid tray Freeze-dried powder injection packaging box

Medical blister packaging supply Oral liquid tray Freeze-dried powder injection packaging box
A Series Depth Filter Sheets With High Absorption

A Series Depth Filter Sheets With High Absorption

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service